Clinical and Functional Analysis of a HABP4 Missense Variant in Chinese Han Women With Endometriosis

In: Discovery Medicine · 2026 · vol. 38(212) · doi:10.24976/discov.med.202638212.221 · W7214064357
article OA: hybrid CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-09-24 ⓘ

The HABP4 p.R379W variant is significantly more frequent in Chinese Han women with ovarian endometriosis, where it promotes cell migration and invasion while lowering specific biochemical levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-24 · read from full text ⓘ

This study investigated the role of a rare missense variant in the Hyaluronan-binding protein 4 (HABP4) gene among Chinese Han women with ovarian endometriosis. Researchers validated the p.R379W variant using Sanger sequencing and found it significantly more frequent in patients than in controls, while functional assays demonstrated that this mutation enhances cell migration and invasion without affecting proliferation. The authors noted that carriers of the variant exhibited lower levels of total bile acids, triglycerides, uric acid, and luteinizing hormone compared to those with the wild-type gene. This paper is centrally about endometriosis — specifically investigating a genetic variant associated with disease pathogenesis and cellular behavior in ovarian lesions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis (EM) is a complex gynecological disease whose underlying molecular mechanisms remain poorly understood. The discovery of cancer driver mutations in endometriotic lesions indicates that EM may share common molecular pathways with malignant tumors. Our previous whole-exome sequencing (WES) results revealed a rare heterozygous missense variant in the coding region of the Hyaluronan-binding protein 4 (HABP4) gene (rs200039443, c.1135C>T, p.R379W), which exhibited a significant difference in frequency between ovarian EM patients and control women. This study aimed to validate the HABP4 rare variant (p.R379W) in EM patients and explored its potential role in the pathogenic process of EM.Methods: Sanger sequencing was performed to validate the HABP4 rare variant (p.R379W) in EM patients, and intergroup comparison was conducted to explore the relationship between HABP4 variant and clinical characteristics. Additionally, in silico analysis was used to predict the pathogenicity of this variant. Construct plasmids of wild-type and mutant HABP4, transfect to ThESCs/Ishikawa cells, and detect cell migration, invasion and proliferation with Transwell and cell counting Kit-8 (CCK-8) assay.Results: The HABP4 rare variant (p.R379W) was identified in 7 of 300 patients with ovarian EM (2.33%), compared with 5 of 779 control women (0.64%) (p = 0.0452). Intergroup comparison demonstrated that levels of total bile acid (TBA), triglyceride (TG), uric acid (UA) and luteinizing hormone (LH) were significantly lower in the HABP4 variant group than in the wild-type group. Functional experiments showed that this variant promoted cell migration and invasion but exerted no effect on cell proliferation.Conclusion: These findings indicate that the HABP4 heterozygous variant (p.R379W) may be associated with the pathogenesis of EM and can be considered as “novel molecular insights” for this disease pathogenesis. Moreover, the present study enriches the spectrum of EM-associated gene mutations in the Chinese population.
Full text 2,137 characters · extracted from oa-html · 5 sections · click to expand

Abstract

Background: Endometriosis (EM) is a complex gynecological disease whose underlying molecular mechanisms remain poorly understood. The discovery of cancer driver mutations in endometriotic lesions indicates that EM may share common molecular pathways with malignant tumors. Our previous whole-exome sequencing (WES) results revealed a rare heterozygous missense variant in the coding region of the Hyaluronan-binding protein 4 (HABP4) gene (rs200039443, c.1135C>T, p.R379W), which exhibited a significant difference in frequency between ovarian EM patients and control women. This study aimed to validate the HABP4 rare variant (p.R379W) in EM patients and explored its potential role in the pathogenic process of EM.

Methods

Sanger sequencing was performed to validate the HABP4 rare variant (p.R379W) in EM patients, and intergroup comparison was conducted to explore the relationship between HABP4 variant and clinical characteristics. Additionally, in silico analysis was used to predict the pathogenicity of this variant. Construct plasmids of wild-type and mutant HABP4, transfect to ThESCs/Ishikawa cells, and detect cell migration, invasion and proliferation with Transwell and cell counting Kit-8 (CCK-8) assay.

Results

The HABP4 rare variant (p.R379W) was identified in 7 of 300 patients with ovarian EM (2.33%), compared with 5 of 779 control women (0.64%) (p = 0.0452). Intergroup comparison demonstrated that levels of total bile acid (TBA), triglyceride (TG), uric acid (UA) and luteinizing hormone (LH) were significantly lower in the HABP4 variant group than in the wild-type group. Functional experiments showed that this variant promoted cell migration and invasion but exerted no effect on cell proliferation.

Conclusion

These findings indicate that the HABP4 heterozygous variant (p.R379W) may be associated with the pathogenesis of EM and can be considered as “novel molecular insights” for this disease pathogenesis. Moreover, the present study enriches the spectrum of EM-associated gene mutations in the Chinese population.

Keywords

- endometriosis - hyaluronan-binding protein 4 - migration - invasion

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-28T06:04:30.917539+00:00
License: CC0 · commercial use OK